← All stocks

HARROW, INC.

HROW Net selling

CIK 0001360214 #2224 in the set updated 18 Sep 2026

Bought (12 mo)

$468.72K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$9.63M

$0.00 on a plan · $450.00K straight out of an exercise

Sold at will

$9.18M

6 of 7 sales

Net

−$9.17M

−$8.72M against sales at will

By person

7 insiders · 13 transactions

158×

Mark L. Baum holds 158 times base salary in stock. $119.85M of shares against $754.91K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark L. Baum last reported holding, valued at $40.00, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Opaleye Management Inc. entity

10% owner

—

$9.18M (6)

−$9.18M

59,428

0.1585%

$2.38M

−83.9%

Shojaei Amir

CHIEF SCIENTIFIC OFFICER

—

$450.00K (1) scheduled

−$450.00K

0.0000%

$0.00

—

BAUM MARK L

CHIEF EXECUTIVE OFFICER

$302.00K (1)

—

+$302.00K

2,996,130

7.99%

$119.85M

+40.2%

BOLL ANDREW R.

PRESIDENT AND CFO

$104.65K (1)

—

+$104.65K

814,679

2.17%

$32.59M

+43.4%

Graves Adrienne L

Director

$31.07K (1)

—

+$31.07K

1,000

0.0027%

$40.00K

—

SILVERNAIL LAUREN P

Director

$31.00K (1)

—

+$31.00K

1,000

0.0027%

$40.00K

—

SAHAREK JOHN P.

CEO & President, ImprimisRx

—

467,388

1.25%

$18.70M

+56.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 15

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 357,909

History held since 3 Nov 2016